Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	To evaluate the immunogenicity in terms of GMT and four fold seroconversion rate of neutralizing antibodies NAbs across the two groups Vaccine and PlaceboTimepoint: baseline; 28 days 6 months	To evaluate the immunogenicity in terms of GMT and four fold seroconversion rate of neutralizing antibodies NAbs across the two groups Vaccine and PlaceboTimepoint: baseline; 28 days 6 months
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
July 30, 2021, 1:30 p.m.	oms	To evaluate the immunogenicity in terms of GMT and four fold seroconversion rate of neutralizing antibodies NAbs across the two groups Vaccine and PlaceboTimepoint: baseline; 28 days 6 months	To evaluate the immunogenicity in terms of GMT and four fold seroconversion rate of neutralizing antibodies NAbs across the two groups Vaccine and PlaceboTimepoint: baseline; 28 days 6 months